MCO

MAK Capital One Portfolio holdings

AUM $714M Turnover 30.43%
1-Year Est. Return 68.07%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+68.07%
3 Year Est. Return
+199.63%
5 Year Est. Return
+307.07%
10 Year Est. Return
+2,541.72%
AUM
$650M
AUM Growth
-$47.9M
Cap. Flow
-$72.3M
Cap. Flow %
-11.12%
Top 10 Hldgs %
95.35%
Holding
19
New
3
Increased
6
Reduced
1
Closed
5
Avg Time Held Equity + Options
2.3 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
3 years
Top 20 Avg Time Held Equity only
2.6 years

Top Buys

Rank Stock Value
1
AUTL icon
Autolus Therapeutics
AUTL
+$17.7M
2
LAB icon
Standard BioTools
LAB
+$13.5M
3
PRO icon
PROS Holdings
PRO
+$12.2M
4
DAWN icon
Day One Biopharmaceuticals
DAWN
+$9.97M
5
SUPV icon
Grupo Supervielle
SUPV
+$9.37M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$41.5M
2
SKY icon
Champion Homes
SKY
+$35.3M
3
ICLR icon
Icon
ICLR
+$26.8M
4
LOMA icon
Loma Negra
LOMA
+$23.9M
5
CTRA icon
Coterra Energy
CTRA
+$22.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.11%
2 Technology 24.9%
3 Miscellaneous 22.92%
4 Industrials 11.75%
5 Healthcare 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SKY icon
1
Champion Homes
SKY
$4.12B
$153M 23.49%
2,000,000
-500,000
-20% -$35.3M
2018 Q2
29 quarters
AGYS icon
2
Agilysys
AGYS
$3.03B
$126M 19.3%
1,192,730
– –
2013 Q2
49 quarters
SKY icon
3
PUT
Champion Homes
SKY
$4.12B
$115M 17.62%
1,500,000
– –
2024 Q4
3 quarters
HSII icon
4
DELISTED
Heidrick & Struggles
HSII
$60.4M 9.29%
1,213,762
+2,264
+0.2% +$109K
2024 Q1
6 quarters
AUTL icon
5
Autolus Therapeutics
AUTL
$450M
$42.4M 6.52%
26,017,616
+9,062,518
+53% +$17.7M
2025 Q2
1 quarter
AGYS icon
6
PUT
Agilysys
AGYS
$3.03B
$34.5M 5.3%
327,600
– –
2024 Q4
3 quarters
PRO icon
7
DELISTED
PROS Holdings
PRO
$32.4M 4.98%
1,413,426
+748,043
+112% +$12.2M
2025 Q2
1 quarter
LAB icon
8
Standard BioTools
LAB
$248M
$20.7M 3.18%
15,931,806
+10,334,384
+185% +$13.5M
2025 Q1
2 quarters
SUPV icon
9
Grupo Supervielle
SUPV
$614M
$19.8M 3.04%
4,000,000
+1,074,732
+37% +$9.37M
2024 Q1
6 quarters
YTRA icon
10
Yatra Online
YTRA
$57.9M
$17M 2.62%
12,170,301
– –
2018 Q3
28 quarters
DAWN icon
11
DELISTED
Day One Biopharmaceuticals
DAWN
$10.2M 1.57%
+1,448,461
New +$9.97M
2025 Q3
0 quarters
PESI icon
12
Perma-Fix Environmental Services
PESI
$272M
$8.24M 1.27%
815,576
+722,966
+781% +$7.99M
2025 Q2
1 quarter
CYRX icon
13
CryoPort
CYRX
$843M
$7.76M 1.19%
+818,162
New +$6.89M
2025 Q3
0 quarters
SMRT icon
14
SmartRent
SMRT
$222M
$4.04M 0.62%
+2,863,923
New +$3.68M
2025 Q3
0 quarters
CTRA icon
15
DELISTED
Coterra Energy
CTRA
– –
-900,000
Closed -$22.8M –
ICLR icon
16
Icon
ICLR
$13B
– –
-184,087
Closed -$26.8M –
INTC icon
17
Intel
INTC
$519B
– –
-1,853,800
Closed -$41.5M –
LOMA icon
18
Loma Negra
LOMA
$1.16B
– –
-2,175,152
Closed -$23.9M –
PDFS icon
19
PDF Solutions
PDFS
$1.79B
– –
-160,020
Closed -$3.42M –

Similar funds

SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
OL
Optas LLC Austin, Texas $714M AUM 38.25% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
HA
Huntleigh Advisors St. Louis, Missouri $714M AUM 62.24% 1-Year Est. Return
TC
Teilinger Capital Houston, Texas $714M AUM 11.06% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $715M AUM 24.33% 1-Year Est. Return
ADIC
Abu Dhabi Investment Council Abu Dhabi, United Arab Emirates $715M AUM
ZAM
Zevin Asset Management Boston, Massachusetts $713M AUM 19.82% 1-Year Est. Return

MAK Capital One's Q3 2025 Portfolio in Review

As of Q3 2025, MAK Capital One held 19 positions worth $650M, down 6.9% from $698M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

MAK Capital One withdrew a net $72.3M in Q3 2025, closing 5 positions and reducing 1 holding. Its most notable exit was Intel, an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 24% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, MAK Capital One opened a new position in Day One Biopharmaceuticals worth $10.2M.

  • MAK Capital One's largest Q3 2025 buy was Day One Biopharmaceuticals: 1,448,461 shares worth $10.2M.
  • MAK Capital One added most to Autolus Therapeutics in Q3 2025, an estimated $17.7M increase.
  • MAK Capital One's biggest Q3 2025 reduction was Champion Homes, cutting an estimated $35.3M.
  • MAK Capital One fully exited Intel in Q3 2025, selling an estimated $41.5M.
  • MAK Capital One's ten largest holdings make up 95% of its $650M portfolio in Q3 2025.
  • MAK Capital One opened 3 new positions and closed 5 in Q3 2025.
  • MAK Capital One's portfolio value fell 6.9% quarter-over-quarter to $650M.

Based on MAK Capital One's 13F filing for Q3 2025, filed 14 Nov 2025.